{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:07:25Z","timestamp":1788930445837,"version":"build-2803163510"},"reference-count":57,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFF0710300"],"award-info":[{"award-number":["2022YFF0710300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"crossref","award":["2026JC-YBQN-1197"],"award-info":[{"award-number":["2026JC-YBQN-1197"]}],"id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioengineering"],"abstract":"<jats:p>Early diagnosis of breast cancer (BC) remains challenging. The limited sensitivity and specificity of existing serum tumor markers for reliable clinical application highlight the need to develop a more accurate and efficient screening workflow. This study analyzed serum samples from 255 breast cancer patients and 300 healthy controls using matrix-assisted laser desorption\/ionization time-of-flight (MALDI-TOF) mass spectrometry, identifying 58 differentially expressed peptides (37 upregulated, 21 downregulated). Combined with machine learning, peptide identification, and external validation, a complete standardized workflow was established. Nine machine learning (ML) algorithms were employed and compared, including SVM, LightGBM, XGBoost, etc. The models were interpreted using SHAP and LIME to identify key features. Peptides of interest were sequenced via mass spectrometry. Their expression and potential prognostic value were further validated in breast cancer transcriptomic datasets. Nine machine learning algorithms showed favorable discriminatory ability in the study cohort. The LightGBM model achieved an AUC of 0.97 internally and maintained an AUC of 0.88, an accuracy of 0.8543, and a precision of 0.9799 externally. However, after correcting for the markedly elevated prevalence (80.3%) in the external cohort, the positive predictive value (PPV) decreased substantially under real-world screening scenarios, warranting prospective validation in true screening populations. Model interpretation and subsequent sequencing identified six core biomarker peptides: Apolipoprotein A-IV (APOA4), Serum Deprivation Response Protein (SDPR), Alpha-1-Antitrypsin (SERPINA1), Ezrin (EZR), Serglycin (SRGN), and Fibrinogen Alpha Chain (FGA). Transcriptomic corroboration suggested that these molecules were significantly dysregulated in breast cancer tissues and showed univariate prognostic associations with patient survival. These findings demonstrated the potential of a proteomics-driven integrated machine learning pipeline as a proof-of-concept auxiliary risk-stratification tool for enhancing early breast cancer diagnosis, warranting further prospective validation in real-world screening cohorts before clinical translation.<\/jats:p>","DOI":"10.3390\/bioengineering13091040","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:23:37Z","timestamp":1788773017000},"page":"1040","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Machine Learning-Enhanced Proteomics to a Validated Diagnostic Model: A Pipeline for Breast Cancer Biomarker Discovery via Independent and Transcriptomic Corroboration"],"prefix":"10.3390","volume":"13","author":[{"given":"Xiaoyan","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710004, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1129-4572","authenticated-orcid":false,"given":"Yue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710004, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Ting","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710004, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3173-7243","authenticated-orcid":false,"given":"Jiali","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710004, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Dongdong","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi\u2019an Jiaotong University Health Science Center, Xi\u2019an 710119, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Yudong","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Shaanxi Provincial Cancer Hospital, Xi\u2019an 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"given":"Nan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710004, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"given":"Sipeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710004, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Hao","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710004, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"software","vocabulary":"credit"}]},{"given":"Ning","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710004, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3744-8805","authenticated-orcid":false,"given":"Qian","family":"He","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710004, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/CCO.0000000000001163","article-title":"Progress in global breast cancer control","volume":"37","author":"Trapani","year":"2025","journal-title":"Curr. Opin. Oncol."},{"key":"ref_2","first-page":"221","article-title":"Cancer incidence and mortality in China, 2022","volume":"46","author":"Zheng","year":"2024","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"ITC161","DOI":"10.7326\/AITC202311210","article-title":"Breast Cancer Screening and Prevention","volume":"176","author":"Farkas","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacr.2017.11.034","article-title":"Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR","volume":"15","author":"Monticciolo","year":"2018","journal-title":"J. Am. Coll. Radiol."},{"key":"ref_5","first-page":"733","article-title":"Prognostic assessment and treatment of early breast cancer","volume":"70","author":"Amsellem","year":"2020","journal-title":"Rev. Prat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.21037\/gs-24-135","article-title":"Diagnostic accuracy of automated breast volume scanning, hand-held ultrasound and molybdenum-target mammography for breast lesions: A systematic review and meta-analysis","volume":"14","author":"Liu","year":"2025","journal-title":"Gland. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.soncn.2017.02.009","article-title":"Early Detection and Screening for Breast Cancer","volume":"33","author":"Coleman","year":"2017","journal-title":"Semin. Oncol. Nurs."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ultrasmedbio.2017.09.012","article-title":"Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review","volume":"44","author":"Guo","year":"2018","journal-title":"Ultrasound Med. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2021.11.007","article-title":"Breast cancer screening in average and high-risk women","volume":"83","author":"Rahman","year":"2022","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11912-023-01372-x","article-title":"Breast MRI: Clinical Indications, Recommendations, and Future Applications in Breast Cancer Diagnosis","volume":"25","author":"Wekking","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.mayocp.2014.02.004","article-title":"Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy","volume":"Volume 89","author":"Neal","year":"2014","journal-title":"Mayo Clinic Proceedings"},{"key":"ref_12","first-page":"1","article-title":"A review of prognostic and predictive biomarkers in breast cancer","volume":"23","author":"Tarighati","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_13","first-page":"252","article-title":"Screening in patients with increased risk of breast cancer (part 1): Pros and cons of MRI screening","volume":"62","author":"Roca","year":"2020","journal-title":"Radiologia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"djx035","DOI":"10.1093\/jnci\/djx035","article-title":"Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies","volume":"109","author":"Visscher","year":"2017","journal-title":"JNCI-J. Natl. Cancer Inst."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5937\/jomb0-45192","article-title":"Expression and clinical significance of CA125, CA153 and CEA in nipple discharge of breast cancer patients","volume":"43","author":"Geng","year":"2024","journal-title":"J. Med. Biochem."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Jia, L., Li, G., Ma, N., Zhang, A., Zhou, Y., Ren, L., and Dong, D. (2022). Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09864-y"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.cell.2020.10.036","article-title":"Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy","volume":"183","author":"Krug","year":"2020","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s43018-024-00725-0","article-title":"Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities","volume":"5","author":"Jiang","year":"2024","journal-title":"Nat. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/D5AY01294E","article-title":"Data independent acquisition mass spectrometry (DIA-MS) in cancer studies: A concise review","volume":"18","author":"Kumar","year":"2026","journal-title":"Anal. Methods"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100800","DOI":"10.1016\/j.mcpro.2024.100800","article-title":"Data-Independent Acquisition: A Milestone and Prospect in Clinical Mass Spectrometry-Based Proteomics","volume":"23","author":"Frohlich","year":"2024","journal-title":"Mol. Cell. Proteom."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Simonik, J., Lapcik, P., Bouchalova, P., and Bouchal, P. (2025). Data-Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research. Mass Spectrom. Rev.","DOI":"10.1002\/mas.70014"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/14789450.2025.2491355","article-title":"Recent implementations of data-independent acquisition for cancer biomarker discovery in biological fluids","volume":"22","author":"Ha","year":"2025","journal-title":"Expert Rev. Proteom."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1021\/acs.chemrestox.3c00223","article-title":"Recent Contributions of Mass Spectrometry-Based \u201cOmics\u201d in the Studies of Breast Cancer","volume":"37","author":"Banerjee","year":"2024","journal-title":"Chem. Res. Toxicol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.21037\/tcr-2025-1092","article-title":"Prospective proteomics for discovering biomarkers in lung adenocarcinoma: A literature review","volume":"14","author":"Wang","year":"2025","journal-title":"Transl. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s40364-025-00837-4","article-title":"Blood proteomics for quantitative biomarkers of cellular therapies","volume":"13","author":"Gafken","year":"2025","journal-title":"Biomark. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100830","DOI":"10.1016\/j.mcpro.2024.100830","article-title":"Secretome Analysis Using Affinity Proteomics and Immunoassays: A Focus on Tumor Biology","volume":"23","author":"Beutgen","year":"2024","journal-title":"Mol. Cell. Proteom."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s42004-025-01665-1","article-title":"Current landscape of plasma proteomics from technical innovations to biological insights and biomarker discovery","volume":"8","author":"Kirsher","year":"2025","journal-title":"Commun. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1074\/mcp.M600162-MCP200","article-title":"Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications","volume":"5","author":"Qian","year":"2006","journal-title":"Mol. Cell. Proteom."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-0716-2978-9_7","article-title":"An Optimized Data-Independent Acquisition Strategy for Comprehensive Analysis of Human Plasma Proteome","volume":"2628","author":"Fang","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12014-025-09567-z","article-title":"Mass spectrometry-based proteomics of FFPE tissues: Progress, limitations, and clinical translation barriers","volume":"22","author":"Nagshabandi","year":"2025","journal-title":"Clin. Proteom."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1021\/pr0500657","article-title":"Utilizing human blood plasma for proteomic biomarker discovery","volume":"4","author":"Jacobs","year":"2005","journal-title":"J. Proteome Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrneurol.2015.173","article-title":"Body fluid biomarkers for multiple sclerosis\u2014The long road to clinical application","volume":"11","author":"Teunissen","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41467-025-67968-y","article-title":"An adaptive, continuous-learning framework for clinical decision-making from proteome-wide biofluid data","volume":"17","author":"Albrecht","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12014-026-09590-8","article-title":"Impact of preanalytical factors on plasma extracellular vesicles and human plasma proteome","volume":"23","author":"Suresh","year":"2026","journal-title":"Clin. Proteom."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1038\/s41588-025-02319-7","article-title":"A standardized framework for circulating blood proteomics","volume":"57","author":"Cai","year":"2025","journal-title":"Nat. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e202400346","DOI":"10.1002\/pmic.202400346","article-title":"Clinical Proteomics, Quo Vadis?","volume":"25","author":"Mischak","year":"2025","journal-title":"Proteomics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/14789450.2025.2606048","article-title":"Identifying biomarkers at an early stage: Overcoming limitations of clinical proteomics","volume":"22","author":"Latosinska","year":"2025","journal-title":"Expert Rev. Proteom."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2159-8290.CD-21-0090","article-title":"Artificial Intelligence in Cancer Research and Precision Medicine","volume":"11","author":"Bhinder","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Sun, F., Zhang, L., and Tong, Z. (2024). Application progress of artificial intelligence in tumor diagnosis and treatment. Front. Artif. Intell., 7.","DOI":"10.3389\/frai.2024.1487207"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13643-022-02082-4","article-title":"Machine learning algorithms to identify cluster randomized trials from MEDLINE and EMBASE","volume":"11","author":"Taljaard","year":"2022","journal-title":"Syst. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Vizza, P., Aracri, F., Guzzi, P.H., Gaspari, M., Veltri, P., and Tradigo, G. (2024). Machine learning pipeline to analyze clinical and proteomics data: Experiences on a prostate cancer case. BMC Med. Inform. Decis. Mak., 24.","DOI":"10.1186\/s12911-024-02491-6"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41597-024-03536-1","article-title":"Machine Learning-Enhanced Extraction of Biomarkers for High-Grade Serous Ovarian Cancer from Proteomics Data","volume":"11","author":"Gunaratne","year":"2024","journal-title":"Sci. Data"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1038\/s41598-023-36159-4","article-title":"Quantifiable peptide library bridges the gap for proteomics based biomarker discovery and validation on breast cancer","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1021\/acs.jproteome.4c00686","article-title":"PeptideForest: Semisupervised Machine Learning Integrating Multiple Search Engines for Peptide Identification","volume":"24","author":"Ranff","year":"2025","journal-title":"J. Proteome Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.path.2017.09.001","article-title":"Core Needle Biopsy of the Breast: An Evaluation of Contemporary Data","volume":"11","author":"Calhoun","year":"2018","journal-title":"Surg. Pathol. Clin."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Avalos-Navarro, G., Bautista-Herrera, L.A., Garibaldi-Rios, A.F., Ramirez-Patino, R., Gutierrez-Garcia, M., Briseno-Alvarez, P., Jave-Suarez, L.F., Reyes-Uribe, E., and Gallegos-Arreola, M.P. (2024). Serum alpha1-AT Levels and SERPINA1 Molecular Analysis in Breast Cancer: An Experimental and Computational Study. Diseases, 13.","DOI":"10.3390\/diseases13010001"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Khan, K., Long, B., Deshpande, G.M., and Fox, P.L. (2020). Bidirectional Tumor-Promoting Activities of Macrophage Ezrin. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207716"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/cas.12879","article-title":"Serum deprivation response inhibits breast cancer progression by blocking transforming growth factor-beta signaling","volume":"107","author":"Tian","year":"2016","journal-title":"Cancer Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1038\/oncsis.2017.53","article-title":"SRGN-TGFbeta2 regulatory loop confers invasion and metastasis in triple-negative breast cancer","volume":"6","author":"Zhang","year":"2017","journal-title":"Oncogenesis"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"124250","DOI":"10.1016\/j.lfs.2026.124250","article-title":"Ezrin (EZR) promotes breast cancer progression and drug resistance: Molecular mechanisms involving STAT3 activation","volume":"390","author":"Huang","year":"2026","journal-title":"Life Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41523-021-00299-5","article-title":"High prevalence of APOA1\/C3\/A4\/A5 alterations in luminal breast cancers among young women in East Asia","volume":"7","author":"Lin","year":"2021","journal-title":"npj Breast Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1073\/pnas.1514663113","article-title":"SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis","volume":"113","author":"Ozturk","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1021\/pr060099u","article-title":"Declining plasma fibrinogen alpha fragment identifies HER2-positive breast cancer patients and reverts to normal levels after surgery","volume":"5","author":"Shi","year":"2006","journal-title":"J. Proteome Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(25)01330-3","article-title":"GBD 2023 Demographics Collaborators. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950\u20132023: A demographic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"Hay","year":"2025","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","article-title":"Clinical implications of the intrinsic molecular subtypes of breast cancer","volume":"24","author":"Prat","year":"2015","journal-title":"Breast"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1039\/D4NP00057A","article-title":"Illuminating the dark space of bioactive peptides with mass spectrometry","volume":"42","author":"Parsley","year":"2025","journal-title":"Nat. Prod. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/s42255-025-01340-8","article-title":"Spatial quantitative metabolomics enables identification of remote and sustained ipsilateral cortical metabolic reprogramming after stroke","volume":"7","author":"Wang","year":"2025","journal-title":"Nat. Metab."}],"container-title":["Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5354\/13\/9\/1040\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:21:41Z","timestamp":1788927701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5354\/13\/9\/1040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["bioengineering13091040"],"URL":"https:\/\/doi.org\/10.3390\/bioengineering13091040","relation":{},"ISSN":["2306-5354"],"issn-type":[{"value":"2306-5354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]}}}